Reactive oxygen metabolites, neutrophils, and the pathogenesis of ischemic‐tissue/reperfusion

Clinical Cardiology

Volumn 16, Issue 1 S, 1993, Pages 19-26

  Korthuis, Ronald J ^a   Granger, D Neil ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

adhesion; antioxidants; CD 11 CD18; granulocytes; ICAM 1; no reflow; oxidants

Indexed keywords

CATALASE; CD11 ANTIGEN; CD18 ANTIGEN; GLYCOPROTEIN; HYDROGEN PEROXIDE; HYDROXYL RADICAL; INTERCELLULAR ADHESION MOLECULE 1; MYELOPEROXIDASE; OXIDIZING AGENT; OXYGEN RADICAL; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SCAVENGER; SUPEROXIDE; SUPEROXIDE DISMUTASE; XANTHINE OXIDASE;

BLOOD FLOW; CELL ADHESION; CELL DAMAGE; CELL INFILTRATION; CONFERENCE PAPER; HEART MUSCLE ISCHEMIA; HUMAN; LIPID PEROXIDATION; NEUTROPHIL; PRIORITY JOURNAL; REPERFUSION INJURY; TISSUE INJURY; VASCULAR ENDOTHELIUM;

ACUTE-PHASE REACTION; ANIMAL; GRANULOCYTES; HUMAN; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION INJURY; NADH, NADPH OXIDOREDUCTASES; NADPH OXIDASE; NEUTROPHILS; REACTIVE OXYGEN SPECIES; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; XANTHINE OXIDASE;

EID: 0027404703     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.4960161307     Document Type: Article

References (92)

1. Role of xanthine oxidase and granulocytes in ischemiareperfusion injury
2. Pathogenesis of ischemia/reperfusion: Role of neutrophil‐endothelial cell adhesion
3. Cellular dysfunction induced by ischemia/reperfusion: Role of reactive oxygen metabolites and granulocytes
4. Ischemia‐reperfusion injury: Role of oxygen‐derived free radicals
5. Mechanisms of postischemic vascular dysfunction in skeletal muscle: Implications for therapeutic intervention
6. Reperfusion of ischemic myocardium
7. Contributions of ischemia and reperfusion to mucosal lesion formation
8. Neutrophil‐mediated microvascular dysfunction in postischemic canine skeletal muscle: Role of granulocyte adherence
9. CD 18‐dependent adherence reactions play an important role in the development of the no‐reflow phenomenon
10. The protection from postischemic injury by xanthine oxidase inhibition: Blockade of free radical generation or purine salvage
11. Hypoxic reperfusion attenuates postischemic microvascular injury
12. Measurement of hydroxy conjugated dienes after ischemia/reperfusion in canine skeletal muscle
13. Phospholipid peroxidation deacylation and remodeling in postischemic skeletal muscle
14. Electron spin resonance investigations of oxygen‐centered free radicals in biological systems
15. Direct detection of radical production in the ischaemic and reperfused myocardium: Current status
16. Direct measurement of free radical generation following reperfusion of ischemic myocardium
17. Spin‐trapping evidence that graded myocardial ischemia alters postischemic superoxide production
18. Demonstration of free radical generation in “stunned” myocardium of intact dogs with the use of the spin trap α‐phenyl‐N‐ tert‐butylnitrone
19. Direct evidence that oxygen‐derived free radicals contribute to postischemic myocardial dysfunction in the intact dog
20. Oxygen radicals: Effects on intestinal vascular permeability
21. Evidence of direct toxic effects of free radicals on the myocardium
22. Differential effects of purine/xanthine oxidase on the electrophysiologic characteristics of ventricular tissues
23. Tune course of structure, function, and metabolic changes due to an exogenous source of oxygen metabolites in the rat heart
24. In vivo infusion of oxygen free radical substrates causes myocardial systolic, but not diastolic, dysfunction
25. Role of iron in postischemic microvascular injury
26. A role for iron in oxidant‐mediated ischemic injury to intestinal microvasculature
27. Increased ultraweak chemiluminescence from rat heart at postischemic oxygenation: Protective role of vitamin E
28. Role of oxygen radicals in cardiac injury due to reoxygenation
29. Prevention of stress injury to the heart and its hypoxic contracture by using the natural antioxidant α‐toco‐pherol
30. Effect of α‐tocopherol on hypoxic‐perfused and reoxygenated rabbit heart muscle
31. Vitamin E and the heart: Possible role as an antioxidant
32. Alpha‐tocopherol attenuates myocardial membrane‐related alterations resulting from ischemia and reperfusion
33. The role of neutrophils and free radicals in the ischemic‐reperfused heart: Why the confusion and controversy?
34. Free radicals and their involvement during long‐term myocardial ischemia and reperfusion
35. Protection against oxygen toxicity by intravenous injection of liposome‐entrapped catalase and superoxide dismutase
36. Transport kinetics for superoxide dismutase and catalase between the plasma and interstitial fluid in the rat small intestine
37. Metabolic sources of reactive oxygen metabolites during oxidant stress and ischemia and reperfusion
38. Tissue destruction by neutrophils
39. Myeloperoxidase as an effective inhibitor of hydroxyl radical production. Implications for the oxidative reactions of neutrophils
40. Free radicals and myocardial ischemia: Overview and outlook
41. Xanthine oxidase: Biochemistry, distribution, and physiology
42. Role of xanthine oxidase in postischemic microvascular injury in skeletal muscle
43. Xanthine oxidase inhibitors attenuate ischemia‐induced vascular permeability changes in the cat intestine
44. Circulating xanthine oxidase mediates lung neutrophil sequestration after intestinal ischemia‐reperfusion
45. The effect of ischemia/reperfusion on adenine nucleotide metabolism and xanthine oxidase production in skeletal muscle
46. Oxidant‐mediated, CD 18‐dependent microvascular dysfunction induced by complement‐activated granulocytes
47. Role of xanthine oxidase inhibitor as free radical scavenger: A novel mechanism of action of allopurinol and oxypurinol in myocardial salvage
48. Allopurinol and oxypurinol are hydroxyl radical scavengers
49. Urate production in the heart
50. Mechanisms of cellular injury: Potential sources of oxygen free radicals in ischemia/reperfusion
51. Morphologic assessment of leukocyte‐endothelial cell interactions in mesenteric venules subjected to ischemia and reperfusion
52. Inflammation in the course of early myocardial ischemia
53. Relationship between the velocity of rolling granulocytes and that of blood flow in venules
54. Role of neutrophils in ischemia/reperfusion‐induced microvascular injury
55. Neutrophil accumulation in ischemic myocardium. Insights into time course, distribution, and mechanism of localization during early reperfusion
56. Involvement of neutrophils in postischaemic damage to the small intestine
57. Antibody against leukocyte integrin (CD 18) prevents reperfusion‐induced lung vascular injury
58. Superoxide mediates reperfusion‐induced leukocyte‐endothelial cell interactions
59. Neutrophil‐derived oxidants promote leukocyte adherence in postcapillary venules
60. CDw 18 dependent adhesion of leukocytes to endothelium and its relevance for cardiac reperfusion
61. Antibody to CD‐18 exerts endothelial and cardiac protective effects in myocardial ischemia and reperfusion
62. Efficacy of a monoclonal antibody (MoAb 60.3) in reducing myocardial injury resulting from ischemia/reperfusion in the ferret
63. Inhibition of polymorphonuclear leukocyte adherence suppresses no‐reflow after focal cerebral ischemia in baboons
64. Effect of in vivo inhibition of neutrophil adherence on skeletal muscle function during ischemia in ferrets
65. Adherent neutrophils mediate permeability after atelectasis
66. Reduction of central nervous system ischemic injury in rabbits using leukocyte adhesion antibody treatment
67. Involvement of neutrophils in postischaemic damage to the small intestine
68. Role of xanthine oxidase and neutrophils in ischemia‐reperfusion injury in rabbit lung
69. Antibody against leukocyte integrin (CD 18) prevents reperfusion‐induced lung vascular injury
70. Antibody against neutrophil adhesion improves reperfusion and limits alveolar infiltrate following unilateral pulmonary artery occlusion
71. Role of ICAM‐1 in neutrophil‐mediated lung vascular injury after occlusion and reperfusion
72. Inhibition of leukocyte adherence by anti‐CD 18 monoclonal antibody attenuates reperfusion injury in the rabbit ear
73. Canine neutrophil activation by cardiac lymph obtained during reperfusion of ischemic myocardium
74. Reduction of experimental canine myocardial reperfusion injury by a monoclonal antibody (anti‐Mo1, anti‐CD 11b) that inhibits leukocyte adhesion
75. (F(ab')2 fragments of anti‐Mo1 (904) monoclonal antibodies do not prevent myocardial stunning
76. The role of intercellular adhesion molecule‐1 (ICAM‐1) in the inflammatory response
77. Coronary endothelial and cardiac protective effects of a monoclonal antibody to intercellular adhesion molecule‐1 in myocardial ischemia and reperfusion
78. Reduction of central nervous system ischemic injury by monoclonal antibody to intercellular adhesion molecule
79. Adherence of neutrophils to canine cardiac myocytes in vitro is dependent on intercellular adhesion molecule‐1
80. Anoxia/reoxygenation induced neutrophil adherence to cultured endothelial cells
81. Neutrophil‐induced oxidative injury of cardiac myocytes. A compartmented system requiring CD11b/CD18‐ICAM‐1 adherence
82. Cytochrome c oxidase and cardiolipin alterations in response to skeletal muscle ischemia and reperfusion
83. Neutrophil adherence to isolated adult canine myocytes: Evidence for a CD 18‐dependent mechanism
84. Mac‐1 (CD11b/CD18) mediates adherence‐dependent hydrogen peroxide production by human and canine neutrophils
85. Neutrophil activation on biological surfaces: Massive secretion of hydrogen peroxide in response to products of macrophages and lymphocytes
86. Respiratory burst in adherent human neutrophils: Triggering by colony stimulating factors CSF‐GM and CSF‐G
87. Role of neutrophilic elastase in postischemic granulocyte extravasation and microvascular dysfunction in skeletal muscle